Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AEYE Health is a digital health company focused on developing artificial intelligence-based solutions for retinal imaging and diagnostics. The company's primary product, AEYE-D, is an FDA-cleared autonomous AI system designed to detect referable diabetic retinopathy from fundus images in primary care settings. By leveraging advanced deep learning algorithms, AEYE Health aims to prevent blindness through early detection and accessible screening for various eye conditions. The company partners with healthcare providers and diagnostic device manufacturers to integrate its diagnostic software into existing clinical workflows.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Al Health Eye Medicine.